Description
Equilab International, Indonesian largest Contract Research Organization (CRO) since 2003, specializes in Bioavailability/Bioequivalence Studies, Clinical Trials, Laboratory Testing, and Dermatology Testing.
Equilab has completed over 1,000 projects, and collaborated with 85+ international and 120+ domestic customers from Asia, Europe, America, Australia, and Africa.
Equilab is a globally recognized CRO that has successfully undergone inspections by the WHO, UK-MHRA, Malaysian NPRA, and BPOM. Our clinical and testing laboratories already accredited ISO/IEC 15189 and ISO/IEC 17025, reflecting our commitment to the highest quality standards and regulatory compliance. Our clinical research reports (CSRs) have been approved by 40+ countries across Asia, Europe, and Africa, including regulatory bodies such as WHO and UK-MHRA. Equilab dedicated to maintain these standards to ensure the utmost integrity and reliability of our research outcomes.